Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


suck pdf from google scholar
PDF vom PMID32940090  :  Publisher

suck abstract from ncbi

Nephropedia Template TP Text

Twit Text FOAVip

Twit Text #

English Wikipedia

  • Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations #MMPMID32940090
  • Sultana J; Mazzaglia G; Luxi N; Cancellieri A; Capuano A; Ferrajolo C; de Waure C; Ferlazzo G; Trifiro G
  • Expert Rev Vaccines 2020[Oct]; 19 (10): 919-936 PMID32940090show ga
  • Introduction Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), has quickly spread around the world. Areas covered This review will discuss the available immunologic and clinical evidence to support the benefit of the influenza, pneumococcal, and tuberculosis vaccines in the context of COVID-19 as well as to provide an overview on the COVID-19-specific vaccines that are in the development pipeline. In addition, implications for vaccination strategies from a public health perspective will be discussed. Expert opinion Some vaccines are being considered for their potentially beneficial role in preventing or improving the prognosis of COVID-19: influenza, pneumococcal and tuberculosis vaccines. These vaccines may have either direct effect on COVID-19 via different types of immune responses or indirect effects by reducing the burden of viral and bacterial respiratory diseases on individual patients and national healthcare system and by facilitating differential diagnoses with other viral/bacterial respiratory disease. On the other hand, a large number of candidate vaccines against SARS-CoV-2 are currently in the pipeline and undergoing phase I, II, and III clinical studies. As SARS-CoV-2 vaccines are expected to be marketed through accelerated regulatory pathways, vaccinovigilance as well as planning of a successful vaccination campaign will play a major role in protecting public health.
  • |*Vaccination[MESH]
  • |COVID-19 Vaccines/*administration & dosage/immunology[MESH]
  • |COVID-19/immunology/*prevention & control[MESH]
  • |Drug Development[MESH]
  • |Humans[MESH]
  • |Pharmacovigilance[MESH]
  • |Public Health[MESH]
  • |SARS-CoV-2/immunology/isolation & purification[MESH]

  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    919 10.19 2020